More convenient proteasome inhibition for improved outcomes

File(s)

Yong K Lancet Onc comment 21 05 2018.docx (45.71 KB)

Accepted version

Show more

Author(s)

Auner, Holger W

Yong, Kwee L

Type

Journal Article

Date Issued

2018-07-01

Date Acceptance

2018-06-01

Citation

Lancet Oncology, 2018, 19 (7), pp.856-858

URI

http://hdl.handle.net/10044/1/63283

DOI

https://www.dx.doi.org/10.1016/S1470-2045(18)30411-X

ISSN

1470-2045

Publisher

Elsevier

Start Page

856

End Page

858

Journal / Book Title

Lancet Oncology

Volume

19

Issue

7

Copyright Statement

© 2018 Elsevier Ltd. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence http://creativecommons.org/licenses/by-nc-nd/4.0/

Identifier

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000437342400030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Subjects

Science & Technology

Life Sciences & Biomedicine

Oncology

RELAPSED MULTIPLE-MYELOMA

BORTEZOMIB

DEXAMETHASONE

CARFILZOMIB

PREDNISONE

MELPHALAN

Publication Status

Published

Date Publish Online

2018-06-01